239 related articles for article (PubMed ID: 16910883)
1. Graves' disease and coexisting struma ovarii: struma expression of thyrotropin receptors and the presence of thyrotropin receptor stimulating antibodies.
Teale E; Gouldesbrough DR; Peacey SR
Thyroid; 2006 Aug; 16(8):791-3. PubMed ID: 16910883
[TBL] [Abstract][Full Text] [Related]
2. Coexistence of Graves' disease, papillary thyroid carcinoma and unilateral benign struma ovarii: case report and review of the literature.
Anastasilakis AD; Ruggeri RM; Polyzos SA; Makras P; Molyva D; Campennì A; Gkiomisi A; Balaris C; Fotiadis PP; Tuccari G; Papachatzopoulos S
Metabolism; 2013 Oct; 62(10):1350-6. PubMed ID: 23806737
[TBL] [Abstract][Full Text] [Related]
3. Coexistence of Graves' disease and struma ovarii: case report and literature review.
Mimura Y; Kishida M; Masuyama H; Suwaki N; Kodama J; Otsuka F; Kataoka H; Yamauchi T; Ogura T; Kudo T; Makino H
Endocr J; 2001 Apr; 48(2):255-60. PubMed ID: 11456276
[TBL] [Abstract][Full Text] [Related]
4. Coexistence of Graves' disease and unilateral functioning Struma ovarii: a case report.
Sitasuwan T; Hanamornroongruang S; Peerapatdit T; Thongtang N
BMC Endocr Disord; 2015 Nov; 15():68. PubMed ID: 26530865
[TBL] [Abstract][Full Text] [Related]
5. Hyperthyroidism during pregnancy due to coexistence of struma ovarii and Graves' disease.
Kung AW; Ma JT; Wang C; Young RT
Postgrad Med J; 1990 Feb; 66(772):132-3. PubMed ID: 2349185
[TBL] [Abstract][Full Text] [Related]
6. Malignant struma ovarii with Graves' disease.
Kano H; Inoue M; Nishino T; Yoshimoto Y; Arima R
Gynecol Oncol; 2000 Dec; 79(3):508-10. PubMed ID: 11104630
[TBL] [Abstract][Full Text] [Related]
7. Hyperthyroidism due to coexistence of Graves' disease and Struma ovarii.
Chiofalo MG; Misso C; Insabato L; Lastoria S; Pezzullo L
Endocr Pract; 2007; 13(3):274-6. PubMed ID: 17599859
[TBL] [Abstract][Full Text] [Related]
8. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
[TBL] [Abstract][Full Text] [Related]
9. Coexistence of struma ovarii and Graves' disease.
Bayot MR; Chopra IJ
Thyroid; 1995 Dec; 5(6):469-71. PubMed ID: 8808098
[TBL] [Abstract][Full Text] [Related]
10. Coexistence of malignant struma ovarii and Graves' disease.
Sussman SK; Kho SA; Cersosimo E; Heimann A
Endocr Pract; 2002; 8(5):378-80. PubMed ID: 15251841
[TBL] [Abstract][Full Text] [Related]
11. Coexistence of Graves' disease and benign struma ovarii in a patient with marked ascites and elevated CA-125 levels.
Guida M; Mandato VD; Di Spiezio Sardo A; Di Carlo C; Giordano E; Nappi C
J Endocrinol Invest; 2005 Oct; 28(9):827-30. PubMed ID: 16370564
[TBL] [Abstract][Full Text] [Related]
12. Pure T3 thyrotoxicosis from a Struma Ovarii characterised by a paradoxical rise in thyroxine on treatment.
Prentice J; Panter K; Attygalle A; Ind T; Prentice M
Endocrinol Diabetes Metab Case Rep; 2020 Mar; 2020():. PubMed ID: 32168467
[TBL] [Abstract][Full Text] [Related]
13. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
[TBL] [Abstract][Full Text] [Related]
14. [Struma ovarii associated with Graves' disease].
Pastorino Casas V; Borghi Torzillo MF; Schere D; Lutfi RJ; Faure EN
Medicina (B Aires); 2018; 78(1):44-46. PubMed ID: 29360077
[TBL] [Abstract][Full Text] [Related]
15. Thyrotoxic adenoma followed by atypical hyperthyroidism due to struma ovarii: clinical and genetic studies.
Ciccarelli A; Valdes-Socin H; Parma J; Khoo SK; Schoumans J; Colao A; Hamoir E; Beckers A
Eur J Endocrinol; 2004 Apr; 150(4):431-7. PubMed ID: 15080771
[TBL] [Abstract][Full Text] [Related]
16. Severe ophthalmopathy developing after treatment of coexisting malignant struma ovarii and Graves' disease.
Wong LY; Diamond TH
Thyroid; 2009 Oct; 19(10):1125-7. PubMed ID: 19772400
[No Abstract] [Full Text] [Related]
17. Struma ovarii: a case report.
Lazarus JH; Richards AR; MacPherson MJ; Dinnen JS; Williams ED; Owen GM; Wade JS
Clin Endocrinol (Oxf); 1987 Dec; 27(6):715-20. PubMed ID: 3455373
[TBL] [Abstract][Full Text] [Related]
18. Serum antibodies reactive with eye muscle antigens and the TSH receptor in a euthyroid subject who developed ophthalmopathy and Graves' hyperthyroidism.
Wall J; Barsouk A; Stolarski C; Kiljanski J; Stachura I; Nebes V; Peele K; Volpe R; Kennerdell J
Thyroid; 1996 Aug; 6(4):353-8. PubMed ID: 8875760
[TBL] [Abstract][Full Text] [Related]
19. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
[TBL] [Abstract][Full Text] [Related]
20. Struma ovarii and the thyroid surgeon.
Gunasekaran S; Kopecka E; Maung KH; England RJ
J Laryngol Otol; 2012 Aug; 126(8):858-60. PubMed ID: 22624934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]